{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:33:35Z","timestamp":1791556415223,"version":"4.3.4"},"reference-count":99,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"First Hospital of Shanxi Medical University","award":["SYYYRC-2022001"],"award-info":[{"award-number":["SYYYRC-2022001"]}]},{"name":"First Hospital of Shanxi Medical University","award":["SYYYRC-2022002"],"award-info":[{"award-number":["SYYYRC-2022002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that colonizes the human gastric mucosa, leading to various gastric diseases. H. pylori infection has become a pressing public health issue that affects more than 50% of the human population worldwide, almost 40 years after its discovery. Traditional treatments, based on the use of bismuth-based triple and quadruple therapies, are effective while facing a series of problems, such as difficulty in patient compliance, the rise of antibiotic resistance, and possible recurrence of infection. Therefore, the development of an efficacious vaccine against H. pylori would be extremely urgent. This review mainly elaborates on the pathogenic mechanism and immune evasion mechanism of H. pylori, as well as various strategies adopted in vaccine development, including whole-cell vaccines, subunit vaccines, DNA vaccines, and live vector vaccines. Animal studies and clinical trials demonstrate that H. pylori vaccines significantly reduce bacterial load and provide cellular immunity over some time. Multiple studies have clarified the advantages and limitations of each candidate vaccine. Although the development of H. pylori vaccines provides benefits to reduce the global burden, there are still significant challenges to developing vaccines in safety, efficacy, and availability. Overcoming these challenges, along with the advancement of vaccine technology, can better prevent and treat H. pylori infection.<\/jats:p>","DOI":"10.3390\/vaccines13050526","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:46:49Z","timestamp":1747295209000},"page":"526","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Helicobacter pylori Vaccine: Mechanism of Pathogenesis, Immune Evasion and Analysis of Vaccine Types"],"prefix":"10.3390","volume":"13","author":[{"given":"Jingwen","family":"Gong","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Hospital of Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Lu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"ref_1","first-page":"587","article-title":"Working group report on schistosomes, liver flukes and Helicobacter pylori","volume":"60","author":"Heseltine","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.3748\/wjg.v31.i7.100044","article-title":"Helicobacter pylori infection and gastric microbiota: Insights into gastric and duodenal ulcer development","volume":"31","author":"Pan","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"afaf047","DOI":"10.1093\/ageing\/afaf047","article-title":"Common occurrence of atrophic gastritis in an ageing non-hospitalised population: An autopsy study","volume":"54","author":"Karhunen","year":"2025","journal-title":"Age Ageing"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Paiva Prudente, T., Mezaiko, E., Nunes Pereira Oliva, H., Yamamoto-Silva, F.P., Santos de Freitas Silva, B., Oliveira Oliva, I., and Risch, H. (2025). Associations between colonization with Helicobacter pylori and risk of gastrointestinal tract cancers: An umbrella review of meta-analyses. Eur. J. Clin. Investig., e14394.","DOI":"10.1111\/eci.14394"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/s41388-024-03169-z","article-title":"IL-17RA\/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth","volume":"43","author":"Lin","year":"2024","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102399","DOI":"10.1016\/j.arr.2024.102399","article-title":"Research progress on Helicobacter pylori infection related neurological diseases","volume":"99","author":"Wang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e70229","DOI":"10.1002\/ctm2.70229","article-title":"Large-scale cluster randomised trial reveals effectiveness of Helicobacter pylori eradication for gastric cancer prevention","volume":"15","author":"Liu","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e70021","DOI":"10.1111\/hel.70021","article-title":"Global Prevalence of Helicobacter pylori Infection-Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta-Analysis","volume":"30","author":"Abdun","year":"2025","journal-title":"Helicobacter"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Huang, A.F., He, C., Sheng, J.W., Jiang, X.T., Li, N.S., Fan, H.Z., and Zhu, Y. (2025). The epidemiological study of family-based Helicobacter pylori screening and its benefits: A cross-sectional study. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-87836-5"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Xie, D., Xu, W., Zhang, Z., Huang, F., and Dai, X. (2025). Epidemiological surveys, antibiotic resistance, and related risk factors of Helicobacter pylori in Quanzhou, China: A cross-sectional study. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-89073-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3748\/wjg.v30.i47.5018","article-title":"Prevalence and associated risk factors of Helicobacter pylori infection in community households in Lanzhou city","volume":"30","author":"Zhou","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13139","DOI":"10.1111\/hel.13139","article-title":"Tracking the Helicobacter pylori Epidemic in Adults and Children in China","volume":"29","author":"Wang","year":"2024","journal-title":"Helicobacter"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13643-025-02816-0","article-title":"A scoping review of worldwide guidelines for diagnosis and treatment of Helicobacter pylori infection","volume":"14","author":"Sun","year":"2025","journal-title":"Syst. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e70025","DOI":"10.1111\/hel.70025","article-title":"Global Population Structure, Virulence Factors and Antibiotic Resistance of Helicobacter pylori: A Pooled Analysis of 4067 Isolates From 76 Countries","volume":"30","author":"Zhu","year":"2025","journal-title":"Helicobacter"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wei, J., Zheng, Z., Wang, X., Jia, B., Sun, M., Wang, J., Wan, Q., Han, M., and Qiu, Y. (2025). Guideline-based bismuth quadruple therapy for Helicobacter pylori infection in China: A systematic review and network meta-analysis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0318937"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chom.2022.10.016","article-title":"Prospects for preventing cancer with anti-microbial prophylactic vaccines","volume":"31","author":"Schiller","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0264-410X(01)00401-7","article-title":"Quantifying the population impact of a prophylactic Helicobacter pylori vaccine","volume":"20","author":"Rupnow","year":"2001","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1111\/hel.70013","article-title":"Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship","volume":"30","author":"Hsu","year":"2025","journal-title":"Helicobacter"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Brisse, M., Vrba, S.M., Kirk, N., Liang, Y., and Ly, H. (2020). Emerging Concepts and Technologies in Vaccine Development. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.583077"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S., and Archambault, D. (2019). Nanoparticle-Based Vaccines Against Respiratory Viruses. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00022"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2147\/IJGM.S474925","article-title":"Immune Cell Crisis and Excess Histopathological Features During the Development and Progression of H. pylori Infection in the Gastric Mucosa","volume":"18","author":"Wang","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yi, M., Chen, S., Yi, X., Zhang, F., Zhou, X., Zeng, M., and Song, H. (2025). Helicobacter pylori infection process: From the molecular world to clinical treatment. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1541140"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"He, B., Hu, Y., Wu, Y., Wang, C., Gao, L., Gong, C., Li, Z., Gao, N., Yang, H., and Xiao, Y. (2025). Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a \"hit-and-run\" paradigm. Cancer Commun, ahead of print.","DOI":"10.1002\/cac2.70004"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e202402783","DOI":"10.26508\/lsa.202402783","article-title":"Helicobacter pylori induces the expression of Lgr5 and stem cell properties in gastric target cells","volume":"7","author":"Nascakova","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"El Khadir, M., Zahir, S.O., Boukhris, S.A., Benajah, D.A., Ibrahimi, S.A., Chbani, L., El Abkari, M., and Bennani, B. (2025). Genotypic diversity of the Helicobacter pylori vacA c region and its correlation with gastric disease outcomes. J. Med. Microbiol., 74.","DOI":"10.1099\/jmm.0.001969"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Chen, S., Li, S., Zheng, Y., Mai, L., and Zhang, X. (2025). Association of Helicobacter pylori related chronic atrophic gastritis and gastric cancer risk: A literature review. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1504749"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-025-01439-3","article-title":"The landcape of Helicobacter pylori-mediated DNA breaks links bacterial genotoxicity to its oncogenic potential","volume":"17","author":"Jbara","year":"2025","journal-title":"Genome Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2418407","DOI":"10.1080\/21505594.2024.2418407","article-title":"Study of the relationships among known virulence genes, coccoid transformation and cytotoxicity of Helicobacter pylori in different clinical diseases","volume":"15","author":"Xiao","year":"2024","journal-title":"Virulence"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rosinke, K., Tachiyama, S., Mr\u00e1sek, J., Liu, J., and Hoover, T.R. (2025). A Helicobacter pylori flagellar motor accessory is needed to maintain the barrier function of the outer membrane during flagellar rotation. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1012860"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jebali, A., Esmaeilzadeh, A., Esmaeilzadeh, M.K., and Shabani, S. (2024). Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-68947-x"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Eletto, D., Mentucci, F., Voli, A., Petrella, A., Porta, A., and Tosco, A. (2022). Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073531"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Fauzia, K.A., Rathnayake, J., Doohan, D., Lamawansa, M.D., Alfaray, R.I., Batsaikhan, S., Phuc, B.H., Waskito, L.A., Tuan, V.P., and Kabamba, E.T. (2025). Beyond Low Prevalence: Exploring Antibiotic Resistance and Virulence Profiles in Sri Lankan Helicobacter pylori with Comparative Genomics. Microorganisms, 13.","DOI":"10.20944\/preprints202501.1220.v1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111815","DOI":"10.1016\/j.isci.2025.111815","article-title":"RNase Y mediates posttranscriptional control of the virulence-associated CncR1 small-RNA in Helicobacter pylori","volume":"28","author":"Pinatel","year":"2025","journal-title":"iScience"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: Mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e0059524","DOI":"10.1128\/iai.00595-24","article-title":"Helicobacter pylori CagA and Cag type IV secretion system activity have key roles in triggering gastric transcriptional and proteomic alterations","volume":"93","author":"Shuman","year":"2025","journal-title":"Infect. Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41419-024-07318-w","article-title":"Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107442","DOI":"10.1016\/j.micpath.2025.107442","article-title":"Expressions of selected microRNAs in gastric cancer patients and their association with Helicobacter pylori and its cag pathogenicity island","volume":"202","author":"Rai","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tim.2023.03.009","article-title":"Masking of typical TLR4 and TLR5 ligands modulates inflammation and resolution by Helicobacter pylori","volume":"31","author":"Pachathundikandi","year":"2023","journal-title":"Trends Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00175.2016","article-title":"TLR9 activation suppresses inflammation in response to Helicobacter pylori infection","volume":"311","author":"Varga","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/onc.2016.158","article-title":"Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system","volume":"35","author":"Varga","year":"2016","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10120-023-01461-7","article-title":"Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6","volume":"27","author":"Zhang","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101470","DOI":"10.1016\/j.jcmgh.2025.101470","article-title":"Decoding the Ability of Helicobacter pylori to Evade Immune Recognition and Cause Disease","volume":"19","author":"Sirit","year":"2025","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2105102","DOI":"10.1080\/19490976.2022.2105102","article-title":"Helicobacter pylori actively suppresses innate immune nucleic acid receptors","volume":"14","author":"Dooyema","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2409924","DOI":"10.1080\/19490976.2024.2409924","article-title":"Helicobacter pylori PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survival","volume":"16","author":"Sit","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Anthofer, M., Windisch, M., Haller, R., Ehmann, S., Wrighton, S., Miller, M., Schernthanner, L., Kufferath, I., Schauer, S., and Jelu\u0161i\u0107, B. (2024). Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1282680"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1016\/j.vaccine.2018.07.073","article-title":"Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant","volume":"36","author":"Holmgren","year":"2018","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/hel.13128","article-title":"Candidate Antigens and the Development of Helicobacter pylori Vaccines","volume":"29","author":"Zhang","year":"2024","journal-title":"Helicobacter"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Tu, Z., Wang, Y., Liang, J., and Liu, J. (2024). Helicobacter pylori-targeted AI-driven vaccines: A paradigm shift in gastric cancer prevention. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1500921"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"111212","DOI":"10.1016\/j.humimm.2024.111212","article-title":"Developing a multi-epitope vaccine against Helicobacter pylori","volume":"86","author":"Sarabi","year":"2025","journal-title":"Hum. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","article-title":"Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cui, M., Ji, X., Guan, F., Su, G., and Du, L. (2024). Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1432968"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Khan, M., Khan, S., Ali, A., Akbar, H., Sayaf, A.M., Khan, A., and Wei, D.Q. (2019). Immunoinformatics approaches to explore Helicobacter pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-49354-z"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e22252","DOI":"10.1096\/fj.202101538RR","article-title":"Immmunoinformatics-based design of a multi-epitope vaccine with CTLA-4 extracellular domain to combat Helicobacter pylori","volume":"36","author":"Ru","year":"2022","journal-title":"FASEB J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e12807","DOI":"10.1111\/hel.12807","article-title":"Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL\/6 mice","volume":"26","author":"Xie","year":"2021","journal-title":"Helicobacter"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Aleraky, D.M., Abuohashish, H.M., Bugshan, A.S., Abdelsalam, M.M., AlHawaj, H.A., AlKhamis, T.T., AlDossary, F.A., Alrayes, N.M., Ragab, Y.M., and AbdelKhalek, Z. (2022). Potential Antigenic Candidates for the Development of Peptide-Based Vaccines to Induce Immunization against Helicobacter pylori Infection in BALB\/c Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112824"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/glycob\/cwac023","article-title":"Chemoenzymatic synthesis of an \u03b1-1,6-glucan-based conjugate vaccine against Helicobacter pylori","volume":"32","author":"Altman","year":"2022","journal-title":"Glycobiology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zhang, F., Chen, J., Zhang, Z., Wu, J., Qu, Y., Ni, L., Zhang, G., Liu, K., and Guo, L. (2025). M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity. J. Nanobiotechnol., 23.","DOI":"10.1186\/s12951-025-03111-9"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ni, X., Liu, Y., Sun, M., Jiang, Y., Wang, Y., Ke, D., Guo, G., and Liu, K. (2024). Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection. Probiotics Antimicrob Proteins, in press.","DOI":"10.1007\/s12602-024-10360-x"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12934-024-02321-4","article-title":"Recombinant L. Lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori Infection","volume":"23","author":"Zhang","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhang, F., Shi, T., Zhang, Z., Wang, S., Liu, J., Li, Y., Wang, X., Liu, K., and Guo, L. (2024). An M cell-targeting recombinant L. Lactis vaccine against four H. pylori adhesins. Appl. Microbiol. Biotechnol., 108.","DOI":"10.1007\/s00253-024-13070-0"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Guo, L., Zhang, F., Wang, S., Li, R., Zhang, L., Zhang, Z., Yin, R., Liu, H., and Liu, K. (2022). Oral Immunization with a M Cell-Targeting Recombinant L. Lactis Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against H. pylori in Mice. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.918160"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2367783","DOI":"10.1080\/21505594.2024.2367783","article-title":"Outer membrane vesicles from genetically engineered Salmonella enterica serovar Typhimurium presenting Helicobacter pylori antigens UreB and CagA induce protection against Helicobacter pylori infection in mice","volume":"15","author":"Liu","year":"2024","journal-title":"Virulence"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ghasemi, A., Wang, S., Sahay, B., Abbott, J.R., and Curtiss, R. (2022). Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1034683"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e0192323","DOI":"10.1128\/jvi.01923-23","article-title":"An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice","volume":"98","author":"Nie","year":"2024","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e12997","DOI":"10.1111\/hel.12997","article-title":"Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines","volume":"28","author":"Katsande","year":"2023","journal-title":"Helicobacter"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e12772","DOI":"10.1111\/hel.12772","article-title":"Immune evaluation of a Saccharomyces cerevisiae-based oral vaccine against Helicobacter pylori in mice","volume":"26","author":"Cen","year":"2021","journal-title":"Helicobacter"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zhang, X., Sang, S., Guan, Q., Tao, H., Wang, Y., and Liu, C. (2022). Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen with and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.894206"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e39433","DOI":"10.1016\/j.heliyon.2024.e39433","article-title":"A new multi-epitope DNA vaccine against Helicobacter pylori infection in a BALB\/c mouse model","volume":"10","author":"Azami","year":"2024","journal-title":"Heliyon"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kaveh-Samani, A., Dalali, S., Kaviani, F., Piri-Gharaghie, T., and Doosti, A. (2024). Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb\/C mice. BMC Immunol., 25.","DOI":"10.1186\/s12865-024-00602-6"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Francis, J.E., Skakic, I., Majumdar, D., Taki, A.C., Shukla, R., Walduck, A., and Smooker, P.M. (2024). Solid Lipid Nanoparticles Delivering a DNA Vaccine Encoding Helicobacter pylori Urease A Subunit: Immune Analyses before and after a Mouse Model of Infection. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021076"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Afkhamipour, M., Kaviani, F., Dalali, S., Piri-Gharaghie, T., and Doosti, A. (2024). Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express-ureF DNA Vaccines. Arch. Immunol. Ther. Exp., 72.","DOI":"10.2478\/aite-2024-0004"},{"key":"ref_75","first-page":"796","article-title":"DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: An in vivo study","volume":"24","author":"Ansari","year":"2021","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chehelgerdi, M., and Doosti, A. (2020). Effect of the cagW-based gene vaccine on the immunologic properties of BALB\/c mouse: An efficient candidate for Helicobacter pylori DNA vaccine. J. Nanobiotechnol., 18.","DOI":"10.1186\/s12951-020-00618-1"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Das, S., Halder, P., Banerjee, S., Mukhopadhyay, A.K., Dutta, S., and Koley, H. (2024). Establishment of an intragastric surgical model using C57BL\/6 mice to study the vaccine efficacy of OMV-based immunogens against Helicobacter pylori. Biol. Open, bio-060282.","DOI":"10.1242\/bio.060282"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sedarat, Z., and Taylor-Robinson, A.W. (2024). Helicobacter pylori Outer Membrane Proteins and Virulence Factors: Potential Targets for Novel Therapies and Vaccines. Pathogens, 13.","DOI":"10.3390\/pathogens13050392"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1021\/acs.orglett.0c03105","article-title":"Total Synthesis and Immunological Evaluation of the Tri-d-glycero-d-manno-heptose Antigen of the Lipopolysaccharide as a Vaccine Candidate against Helicobacter pylori","volume":"22","author":"Wang","year":"2020","journal-title":"Org. Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrgastro.2011.1","article-title":"Vaccinating against Helicobacter pylori infection","volume":"8","author":"Czinn","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_81","first-page":"e12","article-title":"Developing a potent vaccine against Helicobacter pylori: Critical considerations and challenges","volume":"27","author":"Menbari","year":"2024","journal-title":"Expert. Rev. Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e13034","DOI":"10.1111\/hel.13034","article-title":"Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants-A review","volume":"29","author":"Yunle","year":"2024","journal-title":"Helicobacter"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Amaral, R., Concha, T., V\u00edtor, J., Almeida, A.J., Calado, C., and Gon\u00e7alves, L.M. (2025). Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Helicobacter pylori Vaccines in a BALB\/c Mouse Model. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010132"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Chaleshtori, Z.A., Rastegari, A.A., Nayeri, H., and Doosti, A. (2024). Chitosan-LeoA-DNA Nanoparticles Promoted the Efficacy of Novel LeoA-DNA Vaccination on Mice Against Helicobacter pylori. Curr. Microbiol., 81.","DOI":"10.1007\/s00284-024-03642-8"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e12875","DOI":"10.1111\/hel.12875","article-title":"GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection","volume":"27","author":"Vaillant","year":"2022","journal-title":"Helicobacter"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e2300085","DOI":"10.1002\/adhm.202300085","article-title":"Synthetic Self-Adjuvanted Lipopeptide Vaccines Conferred Protection against Helicobacter pylori Infection","volume":"12","author":"Xue","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"105433","DOI":"10.1016\/j.micinf.2024.105433","article-title":"Intranasal immunization with poly I:C and CpG ODN adjuvants enhances the protective efficacy against Helicobacter pylori infection in mice","volume":"27","author":"Sun","year":"2024","journal-title":"Microbes Infect."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2425773","DOI":"10.1080\/21505594.2024.2425773","article-title":"Adjuvants for Helicobacter pylori vaccines: Outer membrane vesicles provide an alternative strategy","volume":"15","author":"Zhang","year":"2024","journal-title":"Virulence"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Okamura, T., Ito, A., Iwaya, Y., Nagaya, T., Hirayama, A., Ota, H., and Akamatsu, T. (2025). Long-term evaluation of Helicobacter pylori screening in school health checkups: An 11-year study in Japan. J. Gastroenterol., ahead of print.","DOI":"10.1007\/s00535-025-02236-w"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00365521.2025.2473020","article-title":"Economic evaluation of preventing gastric cancer by eliminating Helicobacter pylori infection in China","volume":"60","author":"Li","year":"2025","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_91","unstructured":"(2024). Global burden associated with 85 pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Infect. Dis., 24, 868\u2013895."},{"key":"ref_92","first-page":"e202403017","article-title":"Cost-effectiveness analysis of a vaccine for Helicobacter pylori in southern Europe","volume":"98","year":"2024","journal-title":"Rev. Esp. Salud Publica"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Elbehiry, A., Marzouk, E., Abalkhail, A., Sindi, W., Alzahrani, Y., Alhifani, S., Alshehri, T., Anajirih, N.A., ALMutairi, T., and Alsaedi, A. (2024). Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1523991"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.2147\/IDR.S412361","article-title":"How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?","volume":"16","author":"Li","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e70005","DOI":"10.1111\/hel.70005","article-title":"Ethnic Inequity in the Current Approach to H. pylori Testing and Treatment: Linked Data Cohort Analysis","volume":"30","author":"Teng","year":"2025","journal-title":"Helicobacter"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhang, S., Ma, S., Hao, S., Pan, J., Li, Y., Yuan, G., Li, P., Hu, H., and Yu, S. (2025). Fucoidan-modified antibiotic-free nanovesicles: A multidimensional approach to eradicate intracellular and extracellular Helicobacter pylori and restore gastrointestinal homeostasis. Int. J. Biol. Macromol., 307.","DOI":"10.1016\/j.ijbiomac.2025.141786"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12032-025-02650-3","article-title":"Nanomaterials in gastric cancer: Pioneering precision medicine for diagnosis, therapy, and prevention","volume":"42","author":"Liu","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Skakic, I., Taki, A.C., Francis, J.E., Dekiwadia, C., Van, T.T.H., Joe, C.C.D., Phan, T., Lovrecz, G., Gorry, P.R., and Ramsland, P.A. (2024). Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research. Vaccines, 12.","DOI":"10.3390\/vaccines12040410"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/5\/526\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:33:14Z","timestamp":1760031194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/5\/526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":99,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["vaccines13050526"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13050526","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}